Clinical Trial Update: Observational Study of Vismodegib (Erivedge) in Patients Treated in Argentina

View source ↗

Summary

This is a completed observational study of vismodegib (Erivedge) in patients with basal cell carcinoma treated in Argentina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Basal Cell Carcinoma | Status: COMPLETED